Results 211 to 220 of about 2,511,849 (258)
Erratum: [Corrigendum] Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer. [PDF]
Maehana T +5 more
europepmc +1 more source
Preclinical Characterization of XB002, an Anti-Tissue Factor Antibody-Drug Conjugate for the Treatment of Solid Tumors. [PDF]
Kantak S +10 more
europepmc +1 more source
Tissue factor, factor VIII and IX in microvesicle-induced thrombosis and tumor growth of pancreatic cancer. [PDF]
Chou SC +11 more
europepmc +1 more source
Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation. [PDF]
Ahnström J, Petri A, Crawley JTB.
europepmc +1 more source
Inflammatory stimuli and hypoxia on atherosclerotic plaque thrombogenicity: Linking macrophage tissue factor and glycolysis. [PDF]
Maekawa K +14 more
europepmc +1 more source
Correction to "Systematic Study of Tissue Factor Expression in Solid tumors". [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Thrombosis and Haemostasis, 1999
Cell Biology of Tissue Factor Transmembrane receptor tissue factor (TF) initiates the coagulation pathways by serving as the cofactor for coagulation factor VIIa.1 The extracellular domain of TF consists of two fibronectin-type III modules in the orientation of a typical class II cytokine receptor extracellular domain,2 confirming the earlier ...
W, Ruf, B M, Mueller
openaire +2 more sources
Cell Biology of Tissue Factor Transmembrane receptor tissue factor (TF) initiates the coagulation pathways by serving as the cofactor for coagulation factor VIIa.1 The extracellular domain of TF consists of two fibronectin-type III modules in the orientation of a typical class II cytokine receptor extracellular domain,2 confirming the earlier ...
W, Ruf, B M, Mueller
openaire +2 more sources
Seminars in Thrombosis and Hemostasis, 2000
The enzymatic complex of tissue factor (TF) and the blood coagulation factor VIIa is generally considered to be the initiator of coagulation. Coagulation that occurs at the site of luminal injury to an artery is, along with platelet deposition, the cause of arterial thrombosis, which is the leading cause of death in Western society.
P L, Giesen, Y, Nemerson
openaire +2 more sources
The enzymatic complex of tissue factor (TF) and the blood coagulation factor VIIa is generally considered to be the initiator of coagulation. Coagulation that occurs at the site of luminal injury to an artery is, along with platelet deposition, the cause of arterial thrombosis, which is the leading cause of death in Western society.
P L, Giesen, Y, Nemerson
openaire +2 more sources
Pathophysiology of Haemostasis and Thrombosis, 2007
Tissue factor (TF), the key regulator of haemostasis and angiogenesis, is also involved in the pathology of several diseases, including cardiovascular, inflammatory and neoplastic conditions. In the latter, TF is upregulated by cancer cells, as well as by certain host cells, and it is the interactions between these distinct pools of TF-expressing cells
Chloe, Milsom, Janusz, Rak
openaire +2 more sources
Tissue factor (TF), the key regulator of haemostasis and angiogenesis, is also involved in the pathology of several diseases, including cardiovascular, inflammatory and neoplastic conditions. In the latter, TF is upregulated by cancer cells, as well as by certain host cells, and it is the interactions between these distinct pools of TF-expressing cells
Chloe, Milsom, Janusz, Rak
openaire +2 more sources
Seminars in Thrombosis and Hemostasis, 2006
Tissue factor (TF) exhibits a distinct nonuniform tissue distribution. Thus, high levels are found in highly vascularized organs such as the lung, brain, and placenta; intermediate levels in the heart, kidney, intestine, testes, and uterus; and low levels in the spleen, thymus, and liver.
Bjarne, Østerud, Eirik, Bjørklid
openaire +2 more sources
Tissue factor (TF) exhibits a distinct nonuniform tissue distribution. Thus, high levels are found in highly vascularized organs such as the lung, brain, and placenta; intermediate levels in the heart, kidney, intestine, testes, and uterus; and low levels in the spleen, thymus, and liver.
Bjarne, Østerud, Eirik, Bjørklid
openaire +2 more sources

